Cargando…
A longitudinal clinical and MRI evaluation of the treatment with erenumab
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448403/ https://www.ncbi.nlm.nih.gov/pubmed/32845491 http://dx.doi.org/10.1007/s10072-020-04660-7 |
| _version_ | 1783574489925156864 |
|---|---|
| author | Coccia, Alberto Lapucci, Caterina di Poggio, Monica Bandettini Grazzini, Matteo Inglese, Matilde Finocchi, Cinzia |
| author_facet | Coccia, Alberto Lapucci, Caterina di Poggio, Monica Bandettini Grazzini, Matteo Inglese, Matilde Finocchi, Cinzia |
| author_sort | Coccia, Alberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7448403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74484032020-08-27 A longitudinal clinical and MRI evaluation of the treatment with erenumab Coccia, Alberto Lapucci, Caterina di Poggio, Monica Bandettini Grazzini, Matteo Inglese, Matilde Finocchi, Cinzia Neurol Sci Brief Communication Springer International Publishing 2020-08-26 2020 /pmc/articles/PMC7448403/ /pubmed/32845491 http://dx.doi.org/10.1007/s10072-020-04660-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Brief Communication Coccia, Alberto Lapucci, Caterina di Poggio, Monica Bandettini Grazzini, Matteo Inglese, Matilde Finocchi, Cinzia A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title | A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title_full | A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title_fullStr | A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title_full_unstemmed | A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title_short | A longitudinal clinical and MRI evaluation of the treatment with erenumab |
| title_sort | longitudinal clinical and mri evaluation of the treatment with erenumab |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448403/ https://www.ncbi.nlm.nih.gov/pubmed/32845491 http://dx.doi.org/10.1007/s10072-020-04660-7 |
| work_keys_str_mv | AT cocciaalberto alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT lapuccicaterina alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT dipoggiomonicabandettini alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT grazzinimatteo alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT inglesematilde alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT finocchicinzia alongitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT cocciaalberto longitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT lapuccicaterina longitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT dipoggiomonicabandettini longitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT grazzinimatteo longitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT inglesematilde longitudinalclinicalandmrievaluationofthetreatmentwitherenumab AT finocchicinzia longitudinalclinicalandmrievaluationofthetreatmentwitherenumab |